new weight loss drug retatrutide Trial of next-gen weight-loss brings it one step closer to FDA approval Retatrutide Phase 3: 60% Achieved

Visit our shop page to explore our complete range of premium products

Instead of a one-size-fits-all plan, care is personalized based on your health history, weight loss goals, lifestyle, and metabolic needs, so you feel supported at every step of the journey

'cause the goal isn't just a number on the scale

Whether the spectacular preclinical pharmacology of GLP-1R/GcgR co-agonists will translate through successful phase 3 registration trials is a question that will be answered in the coming years, but the pursuit of multifunctional, targeted therapeutics is destined to continue

GLP-1 weight loss injections are prescription medications that mimic natural hormones in the body to regulate appetite and blood sugar levels

Nephron 145, 1-13 (2021)